Back to Authors

Silver, Pete

Mayo Clinic

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell

Citations 1

Development of a Quality Improvement Learning Collaborative to Improve Pediatric Sepsis Outcomes
Larsen, Gitte , Brilli, Richard J., Macias, Charles G. , Niedner, Matthew , Auletta, Jeffery J. , Balamuth, Fran , Campbell, Deborah, Depinet, Holly, Frizzola, Meg , Hueschen, Leslie A. , Lowerre, Tracy, Mack, Elizabeth H. , Paul, Raina, Razzaqi, Faisal, Schafer, Melissa , Scott, Halden F. , Silver, Pete, Wathen, Beth, Lukasiewicz, Gloria, Stuart, Jayne, Riggs, Ruth , Richardson, Troy , Ward, Lowrie, INVESTIGATORS, ON BEHALF OF THE IMPROVING PEDIATRIC SEPSIS OUTCOMES COLLABORATIVE, Auletta, Jeffery J , Silver, Pete, Huskins, W. Charles , INVESTIGATORS, ON BEHALF OF THE IMPROVING PEDIATRIC SEPSIS OUTCOMES COLLABORATIVE

Pediatrics | December 16, 2020 | Volume: 147 | Issue: 1 | Pages: No page available

10.1542/peds.2020-1434 Get It

Pediatric sepsis is a major public health problem. Published treatment guidelines and several initiatives have increased adherence with guideline recommendations and have improved patient outcomes, but the gains are modest, and persistent gaps remain. The Children’s Hospital Association Improving Pediatric Sepsis Outcomes (IPSO) collaborative seeks to improve sepsis outcomes in pediatric emergency departments, ICUs, general care units, and hematology/oncology units. We developed a multicenter quality improvement learning collaborative of US children’s hospitals. We reviewed treatment guidelines and literature through 2 in-person meetings and multiple conference calls. We defined and analyzed baseline sepsis-attributable mortality and hospital-onset sepsis and developed a key driver diagram (KDD) on the basis of treatment guidelines, available evidence, and expert opinion. Fifty-six hospital-based teams are participating in IPSO; 100% of teams are engaged in educational and information-sharing activities. A baseline, sepsis-attributable mortality of 3.1% was determined, and the incidence of hospital-onset sepsis was 1.3 cases per 1000 hospital admissions. A KDD was developed with the aim of reducing both the sepsis-attributable mortality and the incidence of hospital-onset sepsis in children by 25% from baseline by December 2020. To accomplish these aims, the KDD primary drivers focus on improving the following: treatment of infection; recognition, diagnosis, and treatment of sepsis; de-escalation of unnecessary care; engagement of patients and families; and methods to optimize performance. IPSO aims to improve sepsis outcomes through collaborative learning and reliable implementation of evidence-based interventions.